Peters Cameron 4
4 · Karyopharm Therapeutics Inc. · Filed Feb 19, 2019
Insider Transaction Report
Form 4
Peters Cameron
VP of Finance
Transactions
- Award
Restricted Stock Units
2019-02-15+8,500→ 8,500 total→ Common Stock (8,500 underlying) - Award
Stock Option (right to buy)
2019-02-15+17,000→ 17,000 totalExercise: $9.21Exp: 2029-02-14→ Common Stock (17,000 underlying)
Footnotes (3)
- [F1]This option was granted on February 15, 2019. The shares underlying this option vest as to 25% of the shares on February 15, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock.
- [F3]The restricted stock units vest in four equal annual installments beginning February 15, 2020, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date.